Savara Inc Foreign Currency Transaction Loss, before Tax
Savara Inc (SVRA) reported Foreign Currency Transaction Loss, before Tax of $146.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2025-08-13
- Savara Inc foreign currency transaction loss, before tax for the quarter ending 2024-06-30 was $125.00K.
- Savara Inc foreign currency transaction loss, before tax for the quarter ending 2024-03-31 was $21.00K.
- Savara Inc foreign currency transaction loss, before tax for the quarter ending 2017-06-30 was $122.00K, a 45.24% increase year-over-year.
- Savara Inc foreign currency transaction loss, before tax for the quarter ending 2016-06-30 was $84.00K.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month |
|---|---|---|
| 2024-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $146.00K 10-Q · filed 2025-08-13 |
| 2024-03-31 | $21.00K 10-Q · filed 2025-05-13 | |
| 2017-06-30 | $122.00K 10-Q · filed 2017-08-09 | $154.00K 10-Q · filed 2017-08-09 |
| 2016-06-30 | $84.00K 10-Q · filed 2017-08-09 | $72.00K 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |